Early study reveals promising Alzheimer's disease treatment

A drug once approved as an antihistamine in Russia improved thinking processes and ability to function in patients with Alzheimer's disease in a study conducted there, said an expert at Baylor College of Medicine in Houston. The findings are published in the current issue of the journal The Lancet.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news135573279.html">Early study reveals promising Alzheimer's disease treatment</a></p> <p>A drug once approved as an antihistamine in Russia improved thinking processes and ability to function in patients with Alzheimer's disease in a study conducted there, said an expert at Baylor College of Medicine in Houston. The findings are published in the current issue of the journal <i>The Lancet</i>.</p>